Metabolic classification suggests the GLUT1/ALDOB/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer.
Li Y, Tang S, Shi X, Lv J, Wu X, Zhang Y, Wang H, He J, Zhu Y, Ju Y, Zhang Y, Guo S, Yang W, Yin H, Chen L, Gao D, Jin G.
Li Y, et al. Among authors: he j.
Cell Rep Med. 2023 Sep 19;4(9):101162. doi: 10.1016/j.xcrm.2023.101162. Epub 2023 Aug 18.
Cell Rep Med. 2023.
PMID: 37597521
Free PMC article.